Navigation Links
Gene 'Switch' May Help Drive Excess Fluid in Lungs
Date:9/15/2009

Finding could lead to treatments for bronchitis, asthma, researchers say

TUESDAY, Sept. 15 (HealthDay News) -- The discovery of a genetic switch that makes mucus production go into overdrive could potentially lead to better treatments for chronic lung ailments, a new study says.

Excessive mucus production in the lungs can cause illness or death from asthma, cystic fibrosis, bronchitis, common colds and other illnesses. From a biological perspective, it's unclear why the body creates dangerous levels of mucus, the researchers noted in the Sept. 14 online issue of the Journal of Clinical Investigation.

"Everyone has had a stuffed-up nose and cough after two or three weeks of a bad cold, and most over-the-counter cold medications deal with mucus," said Dr. Jeffrey Whitsett, lead author of the study and the head of neonatology, perinatal and pulmonary biology at Cincinnati Children's Hospital Medical Center, in a hospital news release. "We still don't have effective therapies for removing excess mucus, whether it's someone with a cold or chronic lung disease. That's why we still tap on the chests of kids with cystic fibrosis to try and clear it."

In the study, the researchers found that lung cells convert from good cells to bad -- creating mucus in the process. But if a genetic switch is blocked, they can change back to good cells.

However, Whitsett said it will be several years before researchers can figure out how to develop a new treatment based on the results.

More information

Learn more about cystic fibrosis from the Nemours Foundation.



-- Randy Dotinga



SOURCE: Cincinnati Children's Hospital Medical Center, news release, Sept. 14, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Scientists Turn Off Obesity Switch in Mice
2. AUDIO from Medialink and Forest Laboratories: Dangers of Switching Medications
3. Switch to digital mammography leads to increased cancer detection rates
4. People Across the Country are Making The Switch!
5. Scientists locate disease switches
6. For Treatment of Dyslipidemia, Surveyed Physicians are Increasingly Switching Patients to a More Potent Statin Following the ENHANCE and SEAS Trials
7. Herleys Israeli Subsidiary, GMI Eyal, is Selected to Provide Complex Microwave Switch Assemblies for a U.S. Customer
8. The Female Health Company Switches to the NASDAQ Stock Market
9. National Pharmacy Omnicare Pays 'Unusual' Settlement to Resolve Charges of Generic Drug Switching in Delaware Nursing Homes, Resulting From 'Qui Tam' Lawsuit
10. UCSF creates fast, affordable tool for finding gene on-off switches
11. Schering-Plough Flips the Switch on 1.7 MW Rooftop Solar Panel System, One of the Largest in N.J., North America
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene 'Switch' May Help Drive Excess Fluid in Lungs 
(Date:7/11/2014)... Williamsburg, VA (PRWEB) July 11, 2014 Riverside ... Continuing Care (CBCC) in Virginia in late 2012 and ... – ChooseHome – to residents throughout the Williamsburg and Newport ... CBCC programs provide services and benefits to independent older adults ... have access to a safety net of continuing care services ...
(Date:7/11/2014)... TX (PRWEB) July 11, 2014 Last ... their staff. Jim Siddons joins the agency as a ... graduated in 1994 with a Bachelor’s Degree in Business ... of industry experience and will manage everything from performance ... for trucking to the specialized needs for those in ...
(Date:7/11/2014)... Europe is one of the largest consumers ... irrigated land area. The agricultural sector is a significant ... 30.0% of the total water use. The scale and ... region, but far from negligible in most northern ones. ... 60.0% of the water use in most countries, while ...
(Date:7/11/2014)... The “Proteomics Market by Technology (Protein Microarray, ... Resonance, X-ray Crystallography) - Instruments, Reagents & Services ... the major market drivers, restraints, and opportunities in ... the World (RoW). , The proteomics market has ... mainly due to the increasing need of proteomic ...
(Date:7/11/2014)... Pigments are insoluble colorants, which usually ... namely protective coating, opacity, and coloring. These are water ... color to substances such as paper, paints, plastics, and ... upon application impart color to the substance. Some examples ... and hematite. , The coloring action of pigments is ...
Breaking Medicine News(10 mins):Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 3Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 4Health News:Europe Micro Irrigation System Market Driven by Growing Environmental Concerns and Decreasing Water Availability - New Report by MicroMarket Monitor 2Health News:Europe Micro Irrigation System Market Driven by Growing Environmental Concerns and Decreasing Water Availability - New Report by MicroMarket Monitor 3Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 2Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 3Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 4Health News:Americas Pigments Market Worth 1,099 Thousand MT by 2018 - New Report by MicroMarket Monitor 2Health News:Americas Pigments Market Worth 1,099 Thousand MT by 2018 - New Report by MicroMarket Monitor 3
... Beneficial bacteria found in healthy women help to reduce the ... more difficult for the virus to spread, boosting the possibility ... against HIV. , The findings come from physicians and scientists ... Medical Center, who worked together in an effort to learn ...
... a national healthcare,management and technology company, has renewed ... West Virginia to provide Revenue Cycle,Management (RCM), ASP ... physician groups., St. Mary,s Medical Center provides ... in several specialties. MED3OOO,s subsidiary,MED3OOO Health Solutions of ...
... CYT, MONTREAL, Feb. 7 /PRNewswire-FirstCall/ - CryoCath (TSX: CYT), will,hold a ... (Eastern Time) on Thursday, February 14, 2008. The Company,will report its results ... 14., DATE: ... ...
... Gentiva Health,Services, Inc. (Nasdaq: GTIV ), ... announced today that its CareCentrix(R),ancillary care benefit management ... homecare contract with CIGNA HealthCare, which will,provide for ... CIGNA,members through January 31, 2011. The extension amends ...
... employee benefit Increasing animal obesity, more and better pet care ... ... The insurance industry is,going to the dogs ... and cats., Officials ... friends and the growth trends for pet insurance are,only going to accelerate ...
... close ties with parents is obviously good for preschoolers, ... the preschoolers are better able to control their own ... , Thats the finding of a new study conducted ... in the January/February 2008 issue of the journal Child ...
Cached Medicine News:Health News:'Good bacteria' in women give clues for slowing HIV transmission 2Health News:'Good bacteria' in women give clues for slowing HIV transmission 3Health News:St. Mary's Medical Center Renews RCM & Technology With MED3000 2Health News:CryoCath to Hold First Quarter 2008 Conference Call and Webcast 2Health News:Gentiva(R) Health Services and CIGNA HealthCare Extend National Homecare Contract Through January 31, 2011 2Health News:Gentiva(R) Health Services and CIGNA HealthCare Extend National Homecare Contract Through January 31, 2011 3Health News:PetFirst: Pet Insurance To Be More Popular in 2008 2Health News:Close ties between parents and babies yield benefits for preschoolers 2
(Date:7/11/2014)... Research and Markets ( http://www.researchandmarkets.com/research/tjlw9k/immunoprotein ) ... Diagnostic Testing Market - Forecasts to 2019: Expected ... and is expected to be valued at USD ... http://photos.prnewswire.com/prnh/20130307/600769 ... segmented according to immunoprotein types which include immunoglobulins, ...
(Date:7/11/2014)... July 11, 2014 ... Safety & Health Expo 2014 were a ... to London , plus ... exhibition.          (Logo: ... )      (Photo: ...
(Date:7/10/2014)... July 11, 2014  Major advances in radiation ... are being highlighted in a three-day Oncology Summit ... from 10-12 July, 2014.  Renowned national and international cancer experts ... practices and exchange knowledge on modern technologies making ... efficient. The Summit will address ...
Breaking Medicine Technology:Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5
... Aug. 17, 2011 Reportlinker.com announces that ... in its catalogue: Levosimendan ... http://www.reportlinker.com/p0483048/Levosimendan---Comprehensive-patent-search.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology Eliminate unnecessary ... patent information. Pipeline Developer is ...
... 16, 2011 Savient Pharmaceuticals, Inc. (NASDAQ: ... KRYSTEXXA® (pegloticase) Phase III clinical studies in patients with ... The Journal of the American Medical Association ( ... resulted in significant and sustained reductions in uric acid ...
Cached Medicine Technology:Levosimendan - Comprehensive Patent Search 2Levosimendan - Comprehensive Patent Search 3Levosimendan - Comprehensive Patent Search 4Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 2Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 3Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 4Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 5Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 6Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 7Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 8
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: